Clinical Trial Update: The Effects of Aripiprazole on Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the effects of aripiprazole in patients with metabolic syndrome. The study involves conditions including schizophrenia, schizoaff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Metabolic Syndrome
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: New Mexico VA Healthcare System | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED